sulphur burps and semaglutide gross acid reflux 💨 “Sulfur burps” on a GLP-1 medication? Yep… let's talk about it burps on semaglutide semaglutide egg – how to get rid of

Indications and Usage Wegovy (semaglutide) injection is indicated in combination with a reduced calorie diet and increased physical activity: To reduce the risk of major adverse cardiovascular (CV) events (CV death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established CV disease and either obesity or overweight To reduce excess body weight and maintain weight reduction long term in: Adults and pediatric patients 12 years and older with obesity Adults with overweight in the presence of at least one weight-related comorbidity Wegovy (semaglutide) tablets are indicated in combination with a reduced calorie diet and increased physical activity to: Reduce the risk of major adverse cardiovascular (CV) events (CV death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established CV disease and either obesity or overweight Reduce excess body weight and maintain weight reduction long term in adults with obesity or with overweight in the presence of at least one weight-related comorbidity Limitations of Use: Concomitant use of Wegovy tablets or Wegovy injection with other semaglutide-containing products or with any GLP-1 receptor agonist is not recommended References Wegovy [package insert]

Clinical Implications Observational studies have been conducted to provide insights into the clinical roles of the new antidiabetic drugs.61,62 A retrospective cohort study has demonstrated beneficial safety profiles over sulphonylureas, whereas OBrien et al

In situations without a major inflammatory component, the difference may be minimal

doi: 10.3389/fcdhc.2026.1665837 Received 14 July 2025 Revised 07 January 2026 Accepted 07 January 2026 Published 02 February 2026 Volume 7 - 2026 Edited by Zhijie Michael Yu, University Health Network (UHN), Canada Reviewed by Alessando Mattina, IRRCS ISMETT/UPMC, Italy Clara Odilia Sailer, Brigham and Womens Hospital, United States Updates Copyright 2026 Chen, Li, Zhou, Li, Ji, Feng and Song

The new findings in recent years raise more questions about the actual function of GLP-1 and GLP1-RA on taste regulation, like the molecular mechanisms in which the decrease or hypersensitivity of some flavors results from receptor internalization, downregulation of ion channels (such as TRPM5), alterations in neurotransmitter release (ATP/5-HT) (24, 162, 173) or either way for genetic variations and polymorphisms or if it is dependent on the density of specific subpopulations around TBC, since not all patients experience the same effect with medication (151, 158, 176)

For many people, these changes happen slowly over weeks or months